INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Capital Work in Progress History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | - | ₹3.78 Cr | ₹1.37 Cr | ₹2.33 Cr | ₹1.99 Cr |
What is the latest Capital Work in Progress ratio of INDO US BIOTECH ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹3.78 Cr |
| Mar2023 | ₹1.37 Cr |
| Mar2022 | ₹2.33 Cr |
| Mar2021 | ₹1.99 Cr |
How is Capital Work in Progress of INDO US BIOTECH Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹3.78 Cr | 176.37 | |
| Mar2023 | ₹1.37 Cr | -41.20 | |
| Mar2022 | ₹2.33 Cr | 17.07 | |
| Mar2021 | ₹1.99 Cr | - | |
Compare Capital Work in Progress of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹282.2 Cr | -6.7% | 6.9% | -35% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,047.9 Cr | -2.7% | 0.8% | -7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,107.4 Cr | -1.7% | -7.4% | -20.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,910.0 Cr | -1.5% | -10.6% | -18.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹931.3 Cr | -3.7% | -1.7% | -36% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹362.5 Cr | -5.6% | -13.7% | -20.2% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -6.7% |
6.9% |
-35% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses